08:30 - 09:15
| DEBATE SESSION: MANY OR FEW PATIENTS SHOULD UNDERGO PFO CLOSURE?
Until recently PFO closure by endovascular procedure was not generally recommended. However, recently the results of 2 RTCs (CLOSE and REDUCE) and the long-term follow-up of the RESPECT trial were published. These results will have an impact on the current practice. The question now is not "should we close"? but "who to close"? This will be the scope of this debate.
Moderators: Robert Hart, Mc Master University, Canada
Clifford Kavinsky, Rush University Medical Center, USA
|
| Few Patients Defender: Brett Cucchiara, University of Pennsylvania, USA Many Patients Defender: Richard Smalling, UTHealth and Memorial Hermann Heart and Vascular Institute, USA
|
09:15 - 10:00
| PANEL DISCUSSION: COLLABORATIVE MEDICINE
Moderators: James Klaas, Mayo Clinic, USA Christopher Granger, Duke University School of Medicine, USA
- Wolfram Doehner, ESC Council on Stroke; Interdisciplinary Stroke Research Charite, Germany
- James Klaas, Assistant Professor of Neurology, Mayo Clinic, Rochester, USA
- Carmelo Graffagnino, Duke University School of Medicine, USA
- Hooman Kamel, Weill Cornell Medical Center, USA
|
10:00 - 10:30
| Coffee Break, Exhibition & Poster Viewing
|
10:30 - 12:00
| INTERACTIVE CASE DISCUSSION
Moderators: Frances Caprio, Northwestern University, USA Milija Mijajlovic, Neurology Clinic, Clinical Center of Serbia
- Shadi Yaghi, Brown University, USA
- MingMing Ning, Harvard Medical School, USA
- Milija Mijajlovic, Neurology Clinic, Clinical Center of Serbia
|
12:00 - 12:45
| DEBATE SESSION: EXTENSIVE OR LITTLE BURDEN OF ATRIAL FIBRILATION SHOULD TRIGGER TREATMENT?
It is greatly accepted that patients with Embolic Stroke of Unknown Source (ESUS) should go on long-term cardiac monitoring in order to detect sub-clinical AF. However, it is still unknown what is the burden of AF that is clinically relevant to trigger treatment with anticoagulants. This debate will highlight the various opinions: "small vs. extensive" is the dilemma that will be discussed. Moderator: Farzaneh Sorond, Northwestern University, Feinberg School of Medicine, USA
|
| Little Burden Defender: Jeff Healey, McMaster University, Canada Extensive Burden Defender: Rod Passman, Northwestern Memorial Hospital, USA |
12:45 - 14:15
13:00 - 14:00
| Break, Exhibition & Poster Viewing
Non-CME Industry Session organised by Abbott (not included in the main event CME/CPD credit offering)
|
14:15 - 14:45
| KEYNOTE LECTURE: NAVIGATE ESUS TRIAL: WHAT DID WE LEARN?
Chairs: Jeffrey Saver, Geffen School of Medicine at UCLA, USA Ayrton Massaro, Hospital Sirio Libanes, Head of Neurovascular Research Unit, Brazil
|
| - Robert Hart, McMaster University, Canada
|
14:45 - 14:50
| Short break
|
14:50 - 16:40 | SYMPOSIUM: COGNITION AND THE HEART
Cognitive impairment due to vascular pathology of the brain- Vascular Cognitive Impairment (VCI) is an important issue. Understanding the underlying and the related risk factors of VCI as well as the effect of the heart on VCI may have an impact on prevention and treatment of this condition. This symposium will discuss this issue from various aspects.
Chairs:
Philip Gorelick, Thorek Memorial Hospital, USA
Georgios Tsivgoulis, University of Athens, Greece
|
| The Neurovascular Unit and Cognitive Impairment Constantino Iadecola, Feil Family Brain and Mind Research Institute, USA Hypertension, Small Vessel Disease and Cognition Ralph Sacco, Miller School of Medicine, University of Miami, USA - Defining Optimal Brain Health in Adults
Philip Gorelick, Mercy Health Hauenstein Neuroscience Center, USA - Aortic Stenosis, TAVR and Cognition: Imaging and Clinical Findings
Ronald Lazar, University of Alabama at Birmingham, USA
Panel Discussion
|
16:40 - 17:10 | Coffee Break, Exhibition & Poster Viewing |
17:10 - 18:40 | SYMPOSIUM: EMBOLIC STROKE OF UNDETERMINED SOURCE
Stroke due to ESUS imposes difficult clinical dilemma for the treating physician. The magnitude of the problem, practical evaluation and treatment options will be discussed in this symposium.
Chairs:
Ralph Sacco, Miller School of Medicine, University of Miami, USA
Rod Passman, Northwestern Memorial Hospital, USA
|